A detailed history of Jupiter Asset Management LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Jupiter Asset Management LTD holds 69,693 shares of ABT stock, worth $7.83 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
69,693
Holding current value
$7.83 Million
% of portfolio
0.07%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$100.73 - $112.44 $7.02 Million - $7.84 Million
69,693 New
69,693 $7.24 Million
Q1 2023

May 10, 2023

BUY
$96.86 - $114.01 $4.87 Million - $5.74 Million
50,327 New
50,327 $5.1 Million
Q3 2022

Nov 10, 2022

SELL
$96.76 - $112.03 $3.54 Million - $4.1 Million
-36,610 Reduced 27.42%
96,927 $9.38 Million
Q2 2022

Aug 10, 2022

BUY
$102.07 - $123.37 $618,646 - $747,745
6,061 Added 4.75%
133,537 $14.5 Million
Q1 2022

May 11, 2022

SELL
$114.02 - $139.04 $1.23 Million - $1.51 Million
-10,831 Reduced 7.83%
127,476 $15.1 Million
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $2.05 Million - $2.51 Million
17,773 Added 14.75%
138,307 $19.5 Million
Q3 2021

Nov 10, 2021

SELL
$116.66 - $129.06 $114,676 - $126,865
-983 Reduced 0.81%
120,534 $14.2 Million
Q2 2021

Aug 10, 2021

SELL
$105.79 - $124.53 $79.2 Million - $93.2 Million
-748,225 Reduced 86.03%
121,517 $14.1 Million
Q1 2021

May 12, 2021

BUY
$108.84 - $128.23 $60.9 Million - $71.7 Million
559,246 Added 180.11%
869,742 $104 Million
Q4 2020

Feb 10, 2021

BUY
$105.0 - $114.42 $4.59 Million - $5.01 Million
43,758 Added 16.4%
310,496 $34 Million
Q3 2020

Nov 10, 2020

BUY
$91.64 - $111.29 $1.5 Million - $1.82 Million
16,320 Added 6.52%
266,738 $29 Million
Q2 2020

Aug 11, 2020

SELL
$76.57 - $98.0 $10.4 Million - $13.3 Million
-136,140 Reduced 35.22%
250,418 $22.9 Million
Q1 2020

May 12, 2020

BUY
$62.82 - $91.86 $2.81 Million - $4.11 Million
44,747 Added 13.09%
386,558 $30.5 Million
Q4 2019

Feb 11, 2020

BUY
$78.51 - $87.4 $3.42 Million - $3.8 Million
43,523 Added 14.59%
341,811 $29.7 Million
Q3 2019

Nov 13, 2019

BUY
$81.84 - $88.74 $2.31 Million - $2.51 Million
28,278 Added 10.47%
298,288 $24.9 Million
Q2 2019

Aug 12, 2019

BUY
$72.88 - $85.0 $8.2 Million - $9.56 Million
112,489 Added 71.41%
270,010 $22.6 Million
Q1 2019

May 13, 2019

SELL
$66.22 - $80.06 $4.61 Million - $5.58 Million
-69,675 Reduced 30.67%
157,521 $12.6 Million
Q3 2018

Nov 09, 2018

BUY
$60.81 - $73.36 $1.78 Million - $2.14 Million
29,216 Added 14.76%
227,196 $16.7 Million
Q2 2018

Aug 10, 2018

BUY
$57.57 - $63.54 $4.08 Million - $4.5 Million
70,897 Added 55.79%
197,980 $12.1 Million
Q1 2018

May 11, 2018

SELL
$56.27 - $63.62 $614,524 - $694,794
-10,921 Reduced 7.91%
127,083 $7.62 Million
Q4 2017

Feb 12, 2018

BUY
$53.68 - $57.47 $483,120 - $517,230
9,000 Added 6.98%
138,004 $7.88 Million
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $6.2 Million - $6.92 Million
129,004
129,004 $6.88 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Jupiter Asset Management LTD Portfolio

Follow Jupiter Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jupiter Asset Management LTD with notifications on news.